Surgical Staging

In general, cancers are divided into categories or stages, with the assignment with a stage based on the risk for recurrence. For vulvar cancer the final stage depends on the pathologic review of the surgical specimens from the vulva and regional lymph nodes.

Stage IA: These lesions do not require a regional lymph node evaluation because of the low risk of metastasis.

Stage 1B: These tumors have deeper invasion (great than 1mm), but the regional lymph nodes are negative. These patients remain in Stage 1 category since they have a no risk for recurrence.

Stage II: The tumors have a local extension to the urethra, anus or vagina with negative lymph nodes. These patients have a lower risk of recurrence than patients described as Stage III.

Stage III: This stage includes patients with lymph node metastases regardless of size, location or extension of the primary vulvar tumor. The presence and extent of lymph node involvement is the single most important factor in the determining the risk of recurrence.

Spotlight

Learn about progress made this past year in the 2014 State of the State report.

Awareness

2015 National Race to End Women’s Cancer Chair Camille Grammer wants all women to know the symptoms of uterine cancer.

Research

The Foundation for Women’s Cancer is pleased to announce the recipients of its 2014-2015 Research Grant and Prizes. View the PDF.

Education

The next Ovarian Cancer Survivors Course is May 8 in Orlando, FL. For more information, click here.